While Obstructive Sleep Apnea (OSA) affects about five percent of the general pediatric population, 80 percent of children with Down syndrome experience OSA. Continual OSA results in poor health, ...
CHICAGO -- An investigational proximal hypoglossal nerve stimulation device helped control obstructive sleep apnea (OSA), the OSPREY randomized trial showed. The Apnea-Hypopnea Index (AHI) response ...
The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of its ...
Leading Sleep Surgeon Dr. Jordan Weiner Brings Cutting-Edge CPAP Alternative to Arizona Patients SCOTTSDALE, AZ, UNITED STATES, February 13, 2026 /EINPresswire.com ...
A nerve-stimulation treatment for obstructive sleep apnea that originally was approved only for people with body mass indexes (BMIs) in the healthy range recently was extended to patients with BMIs up ...
SCOTTSDALE, AZ, UNITED STATES, February 13, 2026 /EINPresswire.com/ — Dr. Jordan S. Weiner, board-certified otolaryngologist and president of Valley ENT, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results